Folate is a B vitamin whose biological reach extends far beyond any single function: it is required for building DNA, regulating gene expression, producing cellular energy currency, and protecting cells from oxidative damage. Many microorganisms and plants synthesize folate from scratch, but humans lost that ability somewhere in evolutionary history and depend entirely on dietary intake and gut bacteria to supply it. That dependence makes folate a fascinating intersection of biochemistry, evolution, medicine, and public health, with research continuing to uncover roles that go well beyond the vitamin’s textbook association with pregnancy.
How Organisms Build Folate From Scratch
Bacteria, fungi, and plants can manufacture folate through a multi-step pathway that begins with guanosine triphosphate (GTP), one of the basic building blocks cells use for energy and signaling. A chain of enzymatic reactions converts GTP into an intermediate called dihydropteroate, which is then joined to the amino acid glutamate to form dihydrofolate, and finally reduced to the active tetrahydrofolate (THF) form.1Future Medicinal Chemistry. Folate Biosynthesis Pathway: Mechanisms and Insights into Drug Design for Infectious Diseases A second raw material, para-aminobenzoic acid (pABA), feeds into this pathway as well, and organisms that lack the early steps can still finish making folate if they get pABA from food or from neighboring microbes.
In plants, the picture is more complicated because folate assembly is split across different compartments of the cell. The final joining step that produces dihydrofolate happens exclusively in the mitochondria. But the enzymes that attach extra glutamate molecules onto finished folate, turning it into the “polyglutamylated” forms cells actually prefer to use, exist as separate versions in the mitochondria, the cytosol, and the chloroplasts.2PubMed. Tetrahydrofolate biosynthesis in plants: molecular and functional characterization of dihydrofolate synthetase and three isoforms of folylpolyglutamate synthetase in Arabidopsis thaliana Each version is encoded by its own gene, a setup that appears to be unique among organisms with complex cells. The practical upshot is that plants shuttle short-chain folate between compartments and then finish customizing it locally, allowing each part of the cell to stock the specific folate forms it needs for its own chemistry.
Why Humans Cannot Make Folate
Humans, along with other animals, are folate auxotrophs: we lack the enzymes needed to assemble the vitamin from simpler molecules. We get the folate we need from food, primarily as 5-methyltetrahydrofolate (5-methyl-THF), which is the main circulating form in the bloodstream and the form that tissues take up for use.3PubMed. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics Leafy greens, legumes, and liver are rich natural sources. Once folate reaches the small intestine, a specialized transporter called the proton-coupled folate transporter (PCFT) carries it across the intestinal lining and into the body.4PubMed Central. The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption
PCFT works best in the mildly acidic environment of the upper small intestine, with the highest expression in the duodenum and decreasing levels further along the gut.5PubMed. The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs This transporter also plays a critical role at the choroid plexus, the structure that produces cerebrospinal fluid, where it ferries folate from the blood into the central nervous system.6PubMed Central. The proton-coupled folate transporter: physiological and pharmacological roles Mutations in the PCFT gene cause hereditary folate malabsorption, a rare but severe condition in which infants develop anemia and neurological problems because they cannot absorb dietary folate at all.
The Folic Acid Conversion Bottleneck
There is an important distinction between the folate found naturally in food and the folic acid added to supplements and fortified flour. Folic acid is a fully oxidized, synthetic molecule that does not occur in significant amounts in fresh foods. Before the body can use it, an enzyme called dihydrofolate reductase (DHFR) must reduce it to tetrahydrofolate. In humans, this enzyme works remarkably slowly. Measurements from donated human liver tissue showed that DHFR activity per gram of liver was, on average, less than 2% of the activity found in rat liver, with almost a five-fold variation between individual people.7PubMed Central. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake
This sluggish conversion means that when you take a large dose of folic acid, the enzyme can become saturated and unmetabolized folic acid begins circulating in the blood. Research has found that at intake levels around 400 micrograms per day from fortified food, unmetabolized folic acid is likely to appear in serum, while the lower level of roughly 200 micrograms or less from fortification programs seems unlikely to cause this.8PubMed Central. Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum In one supplementation study of women, the proportion with detectable unmetabolized folic acid rose from 65% to 100% after twelve weeks, though the body appeared to partially adapt over time and the effect did not persist at full intensity.9PubMed Central. Circulating Unmetabolized Folic Acid: Relationship to Folate Status and Effect of Supplementation Whether circulating unmetabolized folic acid causes harm is still debated, but the conversion limitation is one reason some clinicians and researchers have advocated for using reduced folate forms like 5-methyl-THF instead of synthetic folic acid in supplements.
What Folate Actually Does Inside Cells
Folate’s central job is to serve as a carrier of single-carbon units, the molecular fragments that cells shuffle around to build and modify other molecules. This network of reactions, called one-carbon metabolism, feeds into three broad categories of work that are essential for every dividing cell.
The first and most widely known function is DNA and RNA synthesis. Folate-derived one-carbon units supply the raw material needed to make purines and thymidylate, which are the building blocks of the genetic code. Without enough folate, cells that divide rapidly, such as blood cells and embryonic tissue, stall and malfunction.10PubMed Central. Folate promotes S-adenosyl methionine reactions and the microbial methylation cycle and boosts ruminants production and reproduction
The second function involves methylation, the chemical tagging process by which cells regulate gene activity. The folate and methionine cycles work together to generate S-adenosylmethionine (SAM), the body’s universal methyl donor. SAM provides the methyl groups that get attached to DNA, to histone proteins around which DNA is wrapped, and to many other molecules.11PubMed Central. One-carbon metabolism and epigenetics: understanding the specificity Through this route, folate status can influence gene expression patterns without changing the underlying DNA sequence, a process central to epigenetics.12PubMed Central. One-carbon metabolism-genome interactions in folate-associated pathologies
The third function, recognized more recently, is the production of NADPH, a molecule cells use as reducing power to neutralize oxidative stress. Research demonstrated that the complete oxidation of a folate intermediate called 10-formyl-tetrahydrofolate generates NADPH in both the mitochondria and the cytosol. When the enzymes responsible for this step were experimentally depleted, cells showed lower ratios of protective antioxidant molecules and became more sensitive to oxidative damage.13PubMed Central. Quantitative flux analysis reveals folate-dependent NADPH production This finding reframed folate metabolism: the pathway had long been valued purely for its one-carbon supply, but it turns out to double as an antioxidant defense system.
Gut Bacteria as a Second Source of Folate
Your gut microbiome is not just a passive bystander when it comes to folate. Many intestinal bacteria carry the genes for folate production, and some produce the vitamin in quantities that rival what you get from food.14PubMed. Bacterial folate biosynthesis and colorectal cancer risk: more than just a gut feeling A large genomic survey of over 500 gastrointestinal bacterial genomes found that folate synthesis genes were widespread. About 13% of those genomes had the full set needed for complete de novo synthesis, and an additional 39% could finish making folate if supplied with the intermediate pABA, which can come from the diet or from other bacteria in the community.15PubMed Central. Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors
The practical significance of this microbial contribution is still being worked out. Most bacterial folate production occurs in the colon, where absorption is less efficient than in the upper small intestine. Still, colonic cells themselves use locally produced folate, and some amount does reach systemic circulation. This means that shifts in gut microbial composition, whether from antibiotics, diet changes, or disease, could affect a person’s overall folate status in ways that are hard to predict from diet alone.
How Antifolate Drugs Exploit the Pathway
Because folate is so critical for cell division, blocking its production or use has been a powerful strategy in both antibiotics and cancer treatment. The antibiotic combination of trimethoprim and sulfamethoxazole is a classic example. Sulfamethoxazole blocks the enzyme that produces dihydropteroate, an early folate precursor, while trimethoprim blocks the conversion of dihydrofolate to the active tetrahydrofolate form. By hitting two sequential steps, the combination is far more effective than either drug alone.16PubMed Central. Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole Critically, these drugs work because bacteria synthesize their own folate; since human cells lack the upstream enzymes, the drugs are selectively toxic to the bacteria.
In cancer therapy, methotrexate takes the opposite approach: rather than targeting microbial folate production, it interferes with folate metabolism inside human cells. When cancer cells are exposed to methotrexate, both purine synthesis and thymidylate synthesis are rapidly shut down. Studies in breast cancer cells showed that within three hours of exposure, these pathways dropped to less than 20% of their normal activity, while dihydrofolate accumulated from less than 1% to more than 30% of the total folate pool.17Journal of Biological Chemistry. Effects of methotrexate on the intracellular folate pools of human breast cancer cells The drug essentially jams the folate recycling machinery, starving rapidly dividing cells of the one-carbon units they need to copy their DNA.
Folate and Neural Tube Defects
The most well-known clinical role of folate is its connection to neural tube defects (NTDs), which are birth defects of the brain and spinal cord that arise when the neural tube fails to close properly during the first few weeks of embryonic development. Taking folic acid supplements around the time of conception prevents roughly 50 to 75% of NTD cases.18PubMed Central. Neural tube defects and folate: case far from closed This finding, established through large randomized trials in the 1990s, drove dozens of countries to mandate folic acid fortification of grain products.
The precise mechanism by which folate prevents NTDs is still not fully understood. The prevailing explanation centers on the methylation and DNA synthesis functions described earlier: neural tube closure demands extremely rapid cell proliferation, and any bottleneck in nucleotide supply or gene regulation can derail the process. Methylation may be especially important, since DNA methylation patterns are being established during this same developmental window.19PubMed Central. Neural tube defects, folic acid and methylation But the remaining 25 to 50% of NTDs that do not respond to folic acid supplementation suggest that folate-independent mechanisms also play a role, and identifying those remains an active research challenge.
Cardiovascular and Homocysteine Connections
Folate also occupies a complicated space in cardiovascular research. Elevated blood levels of the amino acid homocysteine have been associated with increased risk of heart disease, and folate is a key player in the metabolic cycle that converts homocysteine back into methionine. Low folate levels tend to mean higher homocysteine, and supplementation brings homocysteine down. But the relationship goes further than that: studies have found an inverse association between blood folate levels and cardiovascular risk that appears to be independent of homocysteine. Folic acid has been shown to reverse dysfunction in the cells lining blood vessels in patients with cardiovascular disease, and this effect persists even when homocysteine levels are not changed, suggesting folate has direct vascular benefits beyond its role in homocysteine metabolism.20PubMed. Folate, homocysteine, endothelial function and cardiovascular disease
Despite these findings, large randomized trials of folic acid supplementation to prevent heart attacks and strokes have produced mixed results. Lowering homocysteine reliably did not always translate into fewer cardiovascular events. The current thinking is that folate’s vascular effects are real but may matter most in people who are deficient rather than as a supplement for the general population.
Genetic Variation in Folate Metabolism
Not everyone processes folate with the same efficiency. One of the most studied genetic variants affecting folate metabolism is a common change in the MTHFR gene, which encodes the enzyme that produces 5-methyl-THF, the predominant circulating folate form. The C677T variant of MTHFR swaps a single amino acid, making the enzyme less stable and less active. People who carry two copies of this variant tend to have lower blood folate and mildly higher homocysteine concentrations. Common gene variants like this one influence the activity of folate-dependent enzymes and the downstream pathways that rely on them.12PubMed Central. One-carbon metabolism-genome interactions in folate-associated pathologies
The MTHFR C677T variant is common worldwide, with carrier frequencies varying by population. Its clinical significance is a matter of ongoing debate. For most carriers, adequate dietary folate compensates for the reduced enzyme activity. The variant becomes more consequential when folate intake is low, which is why fortification programs may disproportionately benefit people with this genotype. Social media and direct-to-consumer genetic testing have popularized the notion that MTHFR variants require special supplementation with methylfolate instead of folic acid, but the scientific evidence does not broadly support this claim for people eating a normal diet in a country with folate fortification.
Folate and the Brain Beyond Birth
Folate’s role in the nervous system does not end with neural tube closure. The brain has its own dedicated folate transport system, centered on the folate receptor alpha (FRα) at the choroid plexus, which actively moves 5-methyl-THF from the blood into the cerebrospinal fluid. When this system fails, it leads to cerebral folate deficiency (CFD), a condition in which folate levels in the brain drop even when blood levels are normal.21PubMed Central. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
One identified cause of CFD is the production of autoantibodies that bind to FRα and block its function. In one study, 25 of 28 patients with cerebral folate deficiency had high-affinity blocking autoantibodies against membrane-bound folate receptors on the choroid plexus, while none of 28 controls did.22PubMed. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome Children with CFD can develop seizures, movement disorders, and developmental regression. Treatment with folinic acid (leucovorin), a reduced folate that can bypass the blocked receptor through alternative transport, has shown benefit in some cases. Autoantibodies against FRα have also been reported at higher rates in children with autism spectrum disorders, and clinical trials of folinic acid in this group are an active area of investigation.
Evolutionary Loss of Folate Synthesis
From an evolutionary standpoint, the inability of animals to synthesize folate is a case of gene loss tied to lifestyle. Analysis of folate biosynthesis genes across the tree of life has revealed that a fusion of three key genes, folB, folK, and folP, which encode enzymes for consecutive steps in the pathway, appeared early in eukaryotic history. The folK-folP fusion is found broadly across eukaryotes and a scattering of bacteria, suggesting it is ancient. However, many eukaryotic lineages, especially those that adopted heterotrophic lifestyles (eating other organisms rather than synthesizing everything from sunlight or simple chemicals), subsequently lost one or more of these genes.23Genome Biology and Evolution. Complex Patterns of Gene Fission in the Eukaryotic Folate Biosynthesis Pathway When you consistently get a nutrient from food, the selective pressure to maintain the genes for making it yourself relaxes, and mutations that disable those genes accumulate without penalty. Animals are the most prominent example, but other heterotrophic eukaryotes have lost pieces of the pathway independently.
Biotechnological Folate Production
The industrial production of folic acid has historically relied on chemical synthesis, but there is growing interest in biological alternatives. Metabolic engineering of microorganisms to overproduce folate could offer a more sustainable route and potentially deliver the vitamin in its natural, reduced forms rather than as synthetic folic acid. Alongside direct microbial production, researchers have explored biofortification of staple crops and dairy products using folate-producing bacterial strains or genetic modification of the plants themselves.24PubMed Central. Formation of folates by microorganisms: towards the biotechnological production of this vitamin The appeal is obvious: if bread wheat or rice could produce more folate on its own, populations in countries without fortification programs would benefit without requiring changes to food-processing infrastructure. These approaches are still largely at the research stage, but they represent a convergence of the biochemistry of folate synthesis with practical public health goals.